Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Bortezomib. Show all posts
Showing posts with label Bortezomib. Show all posts
Thursday, December 15, 2011

Combination of bortezomib and panobinostat shows promise against advanced multiple myeloma

›
In co\continuation of  my update on Bortezomib... A phase 2 clinical trial has shown that pairing bortezomib with an experimental drug,...
Thursday, July 22, 2010

Proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses - a new hope for autoimmune and inflammatory diseases?

›
In continuation of my update on Bortezomib , I found this info interesting to share with.. Japanese scientists lead by Dr. Koichi ...
2 comments:
Tuesday, December 22, 2009

New three-drug combination for multiple myeloma ! ...

›
The regimen, known as RVD , combined the drugs Revlimid - ( lenalidomide ), Velcade - ( bortezomib ) and dexamethasone , which previously we...
Friday, December 11, 2009

Carfilzomib for multiple myeloma ?

›
The proteasome has emerged as an important target for cancer therapy with the approval of bortezomib , a first-in-class, reversible prote...
Friday, November 6, 2009

Bortezomib for bone cancer in children & teens..

›
We knew that Bortezomib marketed as Velcade by Millennium Pharmaceuticals is the first therapeutic proteasome inhibitor to be tested in...
1 comment:
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.